The effect of phosphatidylserine containing Omega3 fatty-acids on attention-deficit hyperactivity disorder symptoms in children: A double-blind placebo-controlled trial, followed by an open-label extension
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Objective: To study the efficacy and safety of phosphatidylserine (PS) containing Omega3 long-chain polyunsaturated fatty acids attached to its backbone (PS-Omega3) in reducing attention-deficit/ hyperactivity disorder (ADHD) symptoms in children. Method: A 15-week, double-blind, placebo-controlled phase followed by an open-label extension of additional 15 weeks. Two hundred ADHD children were randomized to receive either PS-Omega3 or placebo, out of them, 150 children continued into the extension. Efficacy was assessed using Conners’ parent and teacher rating scales (CRS-P,T), Strengths and Difficulties Questionnaire (SDQ), and Child Health Questionnaire (CHQ). Safety evaluation included adverse events monitoring. Results: The key finding of the double-blind phase was the significant reduction in the Global:Restless/impulsive subscale of CRS-P and the significant improvement in Parent impact-emotional (PE) subscale of the CHQ, both in the PS-Omega3 group. Exploratory subgroup analysis of children with a more pronounced hyperactive/impulsive behavior, as well as mood and behavior-dysregulation, revealed a significant reduction in the ADHD-Index and hyperactive components. Data from the open-label extension indicated sustained efficacy for children who continued to receive PS-Omega3. Children that switched to PS-Omega3 treatment from placebo showed a significant reduction in subscales scores of both CRS-P and the CRS-T, as compare to baseline scores. The treatment was well tolerated. Conclusions: The results of this 30-week study suggest that PS-Omega3 may reduce ADHD symptoms in children. Preliminary analysis suggests that this treatment may be especially effective in a subgroup of hyperactive-impulsive, emotionally and behaviorally-dysregulated ADHD children.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychometric properties of the strengths and difficulties questionnaire
GOODMAN, R. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200111000-00015 · Cited by 6,813
Goodman, R., Ford, T., Simmons, H., Gatward, R., & Meltzer, H. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.6.534 · Cited by 1,818
Meta-Analysis of Neurobehavioral Outcomes in Very Preterm and/or Very Low Birth Weight Children
Aarnoudse-Moens, C. S. H., Weisglas-Kuperus, N., van Goudoever, J. B., & Oosterlaan, J. (2009) · Pediatrics · doi:10.1542/peds.2008-2816 · Cited by 1,587
Gender Differences in ADHD: A Meta-Analysis and Critical Review
GAUB, M., & CARLSON, C. L. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199708000-00011 · Cited by 1,117
Biederman, J., Mick, E., Faraone, S. V., Braaten, E., Doyle, A., Spencer, T., Wilens, T. E., Frazier, E., & Johnson, M. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.36 · Cited by 863
Klin, A., Volkmar, F. R., Sparrow, S. S., Cicchetti, D. V., & Rourke, B. P. (1995) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1995.tb01361.x · Cited by 462 · cited 1×
“, epilepsy, brain tumor); c) failure to respond to two or more adequate courses of stimulant therapy (among those previously treated children); d) pervasive developmental disorder (diagnosed according to DSM-IV criteria) or nonverbal learning disability [19,26]; e) diagnosed with psychotic disorders (e.”
BackgroundMolecular Genetics of Attention Deficit Hyperactivity Disorder
Faraone, S. V., & Mick, E. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.004 · Cited by 411 · cited 1×
“Behavioral genetic investigations and twin studies have suggested that it is a highly heritable disorder, and several genes have been linked to its occurrence [14,37].”
BackgroundKaibuchi, K., Takai, Y., & Nishizuka, Y. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68938-6 · Cited by 367 · cited 1×
“activating protein kinase C [24] and stimulates sodium-potassium dependent ATPases [39].”
BackgroundBiederman, J., Kwon, A., Aleardi, M., Chouinard, V.-A., Marino, T., Cole, H., Mick, E., & Faraone, S. V. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1083 · Cited by 285 · cited 1×
“Subgroup analysis Based on the PP findings, which suggested a possible treatment effect on restless and impulsive behavior, and since ADHD boys were reported to exhibit increased hyperactive/impulsive behavior as compared to girls [4,5,15], we performed an initial gender based analysis aimed to identify a subgroup of…”
ResultVaisman, N., Kaysar, N., Zaruk-Adasha, Y., Pelled, D., Brichon, G., Zwingelstein, G., & Bodennec, J. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1170 · Cited by 160 · cited 3×
“Altogether, the findings of the present study join the accumulating data which support the positive effect of PS containing Omega3 fatty acids in improving executive functions of schoolchildren [41] and in ameliorating other neurological disorders [31,43].”
BackgroundMethodResultEffect of phosphatidylserine on acetylcholine release and content in cortical slices from aging rats
Vannucchi, M. G., & Pepeu, G. (1987) · Neurobiology of Aging · doi:10.1016/0197-4580(87)90034-0 · Cited by 50
Cited by
Sonuga-Barke, E. J. S., Brandeis, D., Cortese, S., Daley, D., Ferrin, M., Holtmann, M., Stevenson, J., Danckaerts, M., van der Oord, S., Döpfner, M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12070991 · Cited by 1,167
Chang, J. P.-C., Su, K.-P., Mondelli, V., & Pariante, C. M. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.160 · Cited by 248
Hawkey, E., & Nigg, J. T. (2014) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.05.005 · Cited by 160
DiNicolantonio, J. J., & O’Keefe, J. H. (2020) · Nutrients · doi:10.3390/nu12082333 · Cited by 147
“These benefits were corroborated in another study in children with ADHD symptoms supplemented with phosphatidylserine-bound omega-3 supplement (providing 120 mg of DHA/EPA plus 300 mg of phosphatidylserine per day) [59].”
ResultHealy-Stoffel, M., & Levant, B. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666180412153612 · Cited by 133
Metadata
- Authors
- Manor, I., Magen, A., Keidar, D., Rosen, S., Tasker, H., Cohen, T., Richter, Y., Zaaroor-Regev, D., Manor, Y., & Weizman, A.
- Venue
- European Psychiatry
- Publisher
- Cambridge University Press (CUP)
- Published
- 2012-07
- Volume
- 27
- Issue
- 5
- Pages
- 335-342
- ISSN
- 0924-9338 (ISSN-L)
- 1778-3585
- OpenAlex
- W2130989603
- Cited by
- 99
- References
- 11
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.